| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.75B | — | +6.8% |
| Cost of Revenue | $2.23B | — | +6.0% |
| Gross Profit | $526.0M | — | +10.0% |
| R&D Expense | $120.0M | — | +26.3% |
| SG&A Expense | $161.0M | — | +11.0% |
| Operating Income | $237.0M | — | -6.7% |
| Interest Expense | $26.0M | — | +4.0% |
| Pre-tax Income | $202.0M | — | -13.3% |
| Income Tax | $60.0M | — | -7.7% |
| Net Income | $141.0M | — | -15.6% |
| EPS (Basic) | $1.89 | — | -12.1% |
| EPS (Diluted) | $1.88 | — | -12.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $342.0M | -43.4% | +6.2% |
| Accounts Receivable | $2.42B | +8.3% | +9.8% |
| Inventory | $947.0M | -4.5% | +3.7% |
| Current Assets | $3.99B | -2.8% | +7.8% |
| Total Assets | $8.47B | -2.0% | +4.4% |
| Current Liabilities | $3.71B | -5.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$76.0M | — | -198.7% |
| Capital Expenditures | $85.0M | — | -16.7% |
| Investing Cash Flow | -$84.0M | — | +9.7% |
| Financing Cash Flow | -$93.0M | — | -263.2% |
| Free Cash Flow | -$161.0M | — | -544.0% |
| -2.4% |
| Long-term Debt | $1.70B | -2.0% | +8.6% |
| Stockholders' Equity | $2.63B | +2.4% | +12.0% |